PF 03716556
CAS No. 928774-43-0
PF 03716556 ( —— )
产品货号. M16652 CAS No. 928774-43-0
PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥470 | 有现货 |
|
10MG | ¥761 | 有现货 |
|
25MG | ¥1482 | 有现货 |
|
50MG | ¥2900 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PF 03716556
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively.
-
产品描述PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively, inhibits gastric acid secretion, displays no activity at Na+,K+-ATPase, used for the treatment of gastroesophageal reflux disease.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点ATPase
-
受体H+/K+-ATPase
-
研究领域Metabolic Disease
-
适应症——
化学信息
-
CAS Number928774-43-0
-
分子量394.48
-
分子式C22H26N4O3
-
纯度>98%(HPLC)
-
溶解度Ethanol: 79 mg/mL (200.26 mM); DMSO: 79 mg/mL (200.26 mM)
-
SMILESCC1=C2[C@@H](CCOC2=CC=C1)NC3=CC(=CN4C3=NC(=C4)C)C(=O)N(C)CCO
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Mori, et al. J Pharmacol Exp Ther. 2009 Feb;328(2):671-9.
产品手册
关联产品
-
Goniothalamin
Goniothalamin is a natural product that has been demonstrated to induce apoptosis in various cancer cell lines, can induce cytotoxicity and apoptosis on RT4 cells, induce apoptosis on HepG2 liver cancer cells via induction of caspase-3 with less sensitivity on the cell line of Chang cells.
-
ATP synthase inhibit...
ATP synthase inhibitor 1 is an inhibitor of the c subunit of the F1/FO-ATP synthase complex. It inhibits mitochondrial permeability transition pore (mPTP) opening and does not affect ATP levels.
-
Fenbufen
Fenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class.